Axogen Inc (AXGN) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Axogen inc   (NASDAQ: AXGN)

Select the Financial Report: Select the Period:


Description of Axogen Inc's Business Segments


Axogen Inc.: Extensive Overview of Segments, Products, and Services

Company Overview:
Axogen Inc. is a pioneering medical technology company that specializes in developing and manufacturing innovative surgical solutions specifically targeted for the repair and regeneration of peripheral nerves. The core mission of Axogen is to enhance patient outcomes and improve the quality of life for individuals who suffer from serious nerve injuries caused by trauma or underlying conditions.



Segments:

Axogen operates primarily in two key segments:

1. Surgical Segment:
This segment focuses on providing groundbreaking surgical solutions tailored for the management of peripheral nerve injuries. Products within this segment are specifically designed to facilitate the repair and restoration of functional nerve pathways damaged by various causes, including surgical trauma, automotive accidents, and sports injuries.

2. Wound Care Segment:
The Wound Care segment centers on delivering specialized products and services for treating chronic and complex wounds. This segment emphasizes the promotion of healing in areas where nerve damage or surgical interventions may lead to slower or complicated recovery processes.



Products:

Axogen offers a comprehensive range of products that support nerve repair and regeneration. Noteworthy products include:

1. Avancee Nerve Graft:
- The Avancee Nerve Graft is a biologically active nerve conduit designed to repair peripheral nerves. This product serves as a bridge across nerve gaps, allowing for the alignment and reconnection of the damaged nerve ends. It incorporates growth factors and extracellular matrix elements to promote enhanced nerve regeneration over time.

2. Axoguarde Nerve Connector:
- The Axoguarde Nerve Connector acts as a biologically active interface that bridges the gap between two severed nerve ends. It is scientifically engineered to encourage nerve regeneration and restore function, utilizing a structure that supports the natural healing process while reducing scarring and inflammation.

3. Axoguarde Nerve Protector:
- This product is a biologically active nerve wrap that provides protection to the injured nerve during the recovery process. The Axoguarde Nerve Protector is designed to prevent mechanical damage to the nerve post-surgery while maintaining a supportive environment for regeneration through its specialized material and properties.

4. NerveGene:
- NerveGene is a proprietary formulation that comprises biologically active components meant to stimulate and promote the growth of nerve cells. It is employed to enhance nerve regeneration and to optimize recovery after surgical interventions, facilitating improved functional recovery for patients.



Services:

In addition to its product offerings, Axogen provides a range of services designed to support healthcare professionals in the treatment of peripheral nerve injuries. Key services include:

1. Education and Training:
- Axogen offers extensive training programs aimed at educating healthcare professionals about nerve repair and regeneration techniques. The education programs focus on the application of Axogens products, providing surgeons and medical personnel with the necessary skills and knowledge to effectively implement these solutions in clinical practice.

2. Clinical Support:
- The company maintains a dedicated clinical support team that assists healthcare providers in utilizing Axogens products. This support includes addressing inquiries, troubleshooting product-related issues, and offering clinical best practices. The goal is to ensure optimal patient outcomes and effective use of the products during surgical procedures.

3. Reimbursement Support:
- Axogen recognizes the complexities associated with healthcare billing and reimbursement. To assist its clients, the company provides comprehensive reimbursement support, helping healthcare professionals navigate the often intricate landscape of insurance claims related to nerve repair and regeneration. This service is designed to facilitate access to the necessary therapies for patients while ensuring that providers are appropriately compensated for their services.



Conclusion:

Axogen Inc. continues to be at the forefront of medical technology for nerve repair, significantly impacting the field through its dedicated segments, innovative products, and robust services. The company remains committed to improving patient lives by providing advanced solutions for peripheral nerve injuries and complex wound care challenges.


Composition of Axogen inc Revenues by Segments

 
United States    185.19 % of total Revenue
Non-US    2.94 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
United States 129.14 185.19 %
Non-US 2.05 2.94 %
Total 69.73 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
United States - -
Non-US - -
Total 23.06 % 13.46 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -1.52 -




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Axogen inc Divisions, Sales by Country

 
U S   U S Segment contribution to total sales 98.77 % of total Revenue
International   International Segment contribution to total sales 1.23 % of total Revenue


Twelve months ended 2025
AXGN s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Total 225.21 100 %
U S 222.44 98.77 %
International 2.77 1.23 %


Twelve months ended 2025
AXGN s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -15.70 -

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Total 20.21 % -
U S 20.73 % -
International -10.23 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.